Rule · DFR · 13 Feb 2026 · Bulletin 2026-2

Bulletin 2026-2: Withdrawal of Bulletin DFR 2024-3

The Oregon Division of Financial Regulation issued Bulletin 2026-2 to withdraw Bulletin DFR 2024-3, which had previously suspended annual price increase reporting requirements. This action follows a Ninth Circuit Court of Appeals ruling that overturned a lower court decision and reinstated the Oregon Drug Price Transparency Program's mandatory reporting obligations. Consequently, prescription drug manufacturers subject to the program must resume filing annual price increase reports effective immediately upon the bulletin's issuance.

OregonOregon Division of Financial Regulation

Lineage: No known changes

RegAlert holds no document that amends or replaces this one. This is not a check that it is in force: confirm with the regulator.

DFR Bulletin No. 3 of 2024Not in RegAlertDFR Bulletin No. 3 of 2024 — Not in RegAlertBulletin 2026-2: Withdrawal ofBulletin DFR 2024-32026-02-13 · this documentBulletin 2026-2: Withdrawal of Bulletin DFR 2024-3 (2026-02-13)
amendssupersedesissued underrefers todashed card: not in RegAlert (or proposed)arrows run from the older text to the one that changes it
The links and the sentences they come from (1)
Supersedes
  • DFR Bulletin No. 3 of 2024Not in RegAlert

    “This bulletin withdraws Bulletin DFR 2024-3 re: Suspension of requirement to file certain annual price increase reports.”

More like this from DFR

DFR published 1 document in the last 30 days. We email you each new one the day it's published.

Source: Oregon Division of Financial Regulation — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works

In RegAlert: added · updated